Michelle Jaffee

MBI kicks off enhanced postdoctoral fellowship with highly competitive stipend and mentorship by leading neuroscientists.

Progranulin loss results in sex-dependent dysregulation of peripheral and central immune system in mice.

Over the last few years, there has been great interest in learning more about the proteins that accumulate in brains affected by various neurodegenerative disorders and the idea that these proteins can spread from one area of the brain to the other. Now, a team of University of Florida neuroscientists…

At the McKnight Brain Institute, teams of researchers are striving to find techniques to help multitudes of seniors to remain independent and active and enjoy life. The latest issue of Florida Physician magazine showcases how UF researchers are looking to slow or avert age-related cognitive decline. Read the story…

What do we know about the type of brain cancer with which Senator John McCain has been diagnosed?

Researchers from a variety of disciplines at UF are on a mission to cure one of modern medicine’s least understood and most painful conditions: trigeminal neuralgia, or TN. Read the story in the latest edition of Florida Physician magazine.

MBI director Todd Golde, M.D., Ph.D., leads teams in the hunt for better treatments for brain disorders.

Flanked by a surgery resident and a technician, surgeon Jessica Ching, M.D., holds a 3D model of a patient’s skull. She carefully turns the model over in her hands, considering just where an implant will replace a piece of missing bone. The patient is Robert Lines, 58, of Ocala, who…

On the second annual memorial and advocacy day to honor the late Richard C. Christensen, M.D., who selflessly served the homeless for 25 years, numerous members of the psychiatry community gathered on the University of Florida campus April 28 to remember their friend, co-worker and mentor. But before they sat…

Duane Mitchell, M.D., Ph.D., co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy and head of the Cancer Therapeutics & Immuno-Oncology program at the UF Health Cancer Center, presented a conversation about the use of immunotherapy to treat brain cancers on Monday, Feb. 13 at 6 p.m.